NoticiasCon ayuda de IA

Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification

Marksans Pharma's Goa facility receives EIR from USFDA, inspection classified as VAI.

Por Mrudula Kulkarni

Editor Gerente - Pharma Now

21 ago 2024Updated Jun 26, 2025 · 2 min de lectura

Compartir Añadir como fuente preferida

Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification — https://www.marksanspharma.com/

Reportaje con ayuda de IA

Reviewed by Mrudula Kulkarni, Editor Gerente - Pharma Now

For its production site in Verna, Goa, Marksans Pharma said that the USFDA had issued an Establishment Inspection Report (EIR), which it has now successfully closed. According to USFDA findings, this facility's inspection categorisation is Voluntary Action Indicated (VAI).

TemasNoticias

Written by

Mrudula Kulkarni

Editor Gerente - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.